[Collateral effects of L-dopa treatment in patients with parkinsonism].
D001145:Arrhythmias, Cardiac / Q000139:chemically induced; D004295:Dihydroxyphenylalanine / Q000009:adverse effects*; D004402:Dysautonomia, Familial / Q000139:chemically induced; D005767:Gastrointestinal Diseases / Q000139:chemically induced; D006402:Hematologic Diseases / Q000139:chemically induced; D006801:Humans; D007024:Hypotension, Orthostatic / Q000139:chemically induced; D001523:Mental Disorders / Q000139:chemically induced; D009069:Movement Disorders / Q000139:chemically induced; D010300:Parkinson Disease / Q000188:drug therapy*
D004295:Dihydroxyphenylalanine
Effetti collaterali in pazienti affetti da parkinsonismo trattati con L-dopa.